A Phase I Trial of Recombinant Human Thrombopoietin (rhTPO)
A Phase I Trial of Recombinant Human Thrombopoietin (rhTPO) in Patients with Delayed Platelet Recovery after Hematopoietic Stem Cell Transplantation
Richard A. Nash, Razelle Kurzrock, John DiPersio, Julie Vose, Charles Linker, Dipnarine Maharaj, Auayporn P. Nademanee, Robert Negrin, Stephen Nimer, Howard Shulman, Mark Ashby, Dennie Jones, Frederick R. Appelbaum, Richard Champlin
Biology of Blood and Marrow Transplantation 2000;6:25-34
Nash.pdf
Copyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.
|
|